US 8,119,856

Application 11/811,120 · Granted Feb 21, 2012

Resistance to downy mildew of onion caused by the fungus peronospora destructor

Estimated expiration

December 24, 2027

1y 32d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
  • Could not fetch continuity data for application PCTEP2005013537: Resource not found (404)
Earliest effective filing
Nov 25, 2005
+ 20 years
Nov 25, 2025
PTA +759d
Dec 24, 2027
No TD
—
Final
Dec 24, 2027

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
June 7, 2007
Earliest effective filing
November 25, 2005
Issue date
February 21, 2012
PTA
+759 days
Base expiry (before PTA)
November 25, 2025

November 25, 2005 + 20 years = November 25, 2025 + 759 PTA days = December 24, 2027

  • Continuation of application PCTEP2005013537, filed Nov 25, 2005

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 11/811,120 · US 8,119,856

PatentReply compiles the prosecution history behind US 8,119,856: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US8119856

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.